Poly Medicure (NSE:POLYMED) Cyclically Adjusted PB Ratio: (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:POLYMED Poly Medicure Ltd NSE:POLYMED
100 GF Score
Price ₹1,733.00
GF Value ₹2,443.79
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Poly Medicure Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Poly Medicure  (NSE:POLYMED) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Poly Medicure Cyclically Adjusted PB Ratio Related Terms


Poly Medicure Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Poly Medicure's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poly Medicure Cyclically Adjusted PB Ratio Chart

Poly Medicure Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 25.76 24.74 9.51

Poly Medicure Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 17.77 0.00 9.51 0.00

NSE:POLYMED vs ISRG, BDX, MDLN: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Poly Medicure's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poly Medicure Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Poly Medicure's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Poly Medicure's Cyclically Adjusted PB Ratio falls into.


NSE:POLYMED
100GF Score
Poly Medicure Ltd NSE:POLYMED
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Poly Medicure Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Poly Medicure's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Poly Medicure's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Poly Medicure Quarterly Data

Book Value per Share CPI Adj_Book
201303 12.765 85.687 24.932
201403 16.618 91.425 30.420
201503 22.235 97.163 38.298
201603 26.176 102.518 42.731
201703 30.777 105.196 48.963
201712 0.000 109.404 0.000
201803 38.344 109.786 58.451
201806 0.000 111.317 0.000
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 43.221 118.202 61.195
201906 0.000 120.880 0.000
201909 46.241 123.175 62.827
201912 0.000 126.235 0.000
202003 49.273 124.705 66.126
202006 0.000 127.000 0.000
202009 56.261 130.118 72.363
202012 0.000 130.889 0.000
202103 100.705 131.771 127.902
202106 0.000 134.084 0.000
202109 106.150 135.847 130.772
202112 0.000 138.161 0.000
202203 113.397 138.822 136.706
202206 0.000 142.347 0.000
202209 118.274 144.661 136.830
202212 0.000 145.763 0.000
202303 129.412 146.865 147.469
202306 0.000 150.280 0.000
202309 139.460 151.492 154.065
202312 0.000 152.924 0.000
202403 153.177 153.035 167.513
202406 0.000 155.789 0.000
202409 255.824 157.882 271.177
202412 0.000 158.323 0.000
202503 272.947 157.552 289.934
202506 0.000 159.755 0.000
202509 287.922 162.289 296.913
202512 0.000 163.281 0.000
202603 306.453 164.272 312.208
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Poly Medicure (NSE:POLYMED) Overvalued in 2026?

Based on GuruFocus' analysis, Poly Medicure stock appears to be undervalued. The current stock price of ₹1,733.00 is trading 29.1% below its estimated GF Value™ of ₹2,443.79. GuruFocus considers Poly Medicure to be Modestly Undervalued.

Key valuation signals for NSE:POLYMED:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹2,443.79 vs. price of ₹1,733.00 (29.1% below fair value)
  • GF Score™: 100/100 with 6 warning signs

No single metric tells the full story. See the NSE:POLYMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Poly Medicure Business Description

Other Exchanges 531768:India
Address Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.
100GF Score

Get the complete analysis for NSE:POLYMED

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,733.00
Price
₹2,443.79
GF Value